Ginkgo Bioworks Holdings (DNA) Gains from Sales and Divestitures (2021 - 2023)

Ginkgo Bioworks Holdings has reported Gains from Sales and Divestitures for 3 years, with the latest figure at $27.2 million in Q2 2023.

• For the quarter ending Q2 2023, Gains from Sales and Divestitures rose 6183.36% year-over-year to $27.2 million; the trailing twelve-month figure through Jun 2023 stood at $27.2 million (up 6183.36% YoY), and the FY2022 full-year result was $178531.0, down 24.49% from the prior year.
• Gains from Sales and Divestitures for Q2 2023 stood at $27.2 million, up from $11.8 million in the prior quarter.
• The five-year high for Gains from Sales and Divestitures was $27.2 million in Q2 2023, with the low at $44632.0 in Q1 2022.
• Historically, Gains from Sales and Divestitures has averaged $9.1 million across 3 years, with a median of $433160.0 in 2022.
• Annual changes were most pronounced in 2022 — Gains from Sales and Divestitures declined 24.49% — and 2023, when it soared 26389.96%.
• Ginkgo Bioworks Holdings' Gains from Sales and Divestitures stood at $236427.0 in 2021, then dropped by 24.49% to $178531.0 in 2022, then jumped by 15144.97% to $27.2 million in 2023.
• The last three Gains from Sales and Divestitures figures came in at $27.2 million (Q2 2023), $11.8 million (Q1 2023), and $178531.0 (Q4 2022), per Business Quant data.